Viewing nowEsomeprazole Magnesium Trihydrate Tablets 40 mg
Esomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Aprogen Bio Logistics Co., Ltd.

MFDS item code 201508409 · Approved 2015.12.23 · Insurance code 645208900
Treatment and prevention of reflux, Zollinger-Ellison syndrome, ulcers, and gastrointestinal disorders associated with anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease, especially erosive reflux esophagitis, and to prevent the recurrence in patients with esophagitis. It also alleviates symptoms of gastroesophageal reflux disease without esophagitis. It is effective in treating duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection and preventing their recurrence. It is also used for relief of upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory analgesics and treatment and prevention of gastric and duodenal ulcers. It is applicable for maintenance therapy following prevention of rebleeding caused by intravenous-induced gastric or duodenal ulcers. Overall, this medication effectively improves gastrointestinal diseases and ulcer-related issues.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended for controlling subsequent symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses exceeding 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous injection. No dose adjustment is necessary. Since there is limited experience with administration to patients with severe renal impairment, administer with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, this medicine should not be administered at doses exceeding 20 mg. No dose adjustment is necessary.
Adolescents 12 years and older Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. Children under 12 years There is no experience with administration of this medicine to children under 12 years.
This medication should not be used by patients who have had allergic reactions or hypersensitivity to certain ingredients or benzimidazoles. Additionally, patients allergic to antibiotics such as amoxicillin or clarithromycin should not be given this medication when used in combination for Helicobacter pylori eradication therapy. This medication is also contraindicated in patients with a history of certain antiviral treatments or heart diseases, and in breastfeeding women. Since this medication contains lactose, those with lactose intolerance or specific metabolic disorders should avoid taking it. While taking this medication, various adverse reactions such as blood-related issues, allergic reactions, electrolyte imbalances, neurological symptoms, and gastrointestinal problems may occur rarely, so if any unusual symptoms appear, immediate consultation with a physician is necessary. Long-term use of this medication requires regular examinations, especially electrolyte tests such as magnesium levels if used for more than one year. This medication may increase the risk of infections as it reduces stomach acid and allows bacterial growth; therefore, if diarrhea persists, medical personnel should be notified. This medication may interact with other drugs, so current medications should be disclosed to a physician or pharmacist, particularly when taken with anticoagulants, antibiotics, antivirals, anticonvulsants, etc. Safety data for this medication during pregnancy is limited; therefore, it should be used cautiously after consulting a doctor if pregnant. Breastfeeding women are advised not to take this medication and should always consult with a medical professional.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, exacerbated constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin levels, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbated arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbated migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular eruption, otitis media, abnormal olfaction, loss of taste, taste perversion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal strictures, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature to maintain the effectiveness of the medication for a longer period.
Pink round film-coated tablet
28 tablets (14 tablets/Alu-Alu × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Aprogen Bio Logistics Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.